 Hepatitis virus infection chronic liver disease children leukemia long-term remission Antibody hepatitis virus HCV sera leukemic children chronic liver disease CLD years therapy withdrawal patients anti-HCV regular intervals Ortho-enzyme-linked immunosorbent assay ELISA test cases Reactive sera recombinant assay specificity results ELISA Twelve cases positive group anti-HCV+ positive group negative Mean SGPT peak follow-up group SGPT off-therapy cases group group group histology available patients signs chronic hepatitis patients group patients group severe liver lesions results HCV significant role etiology chronic hepatitis leukemic patients persistent anti-HCV activity severe CLD final prognosis children leukemia